# Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's Disease

> **NCT01434693** · PHASE1 · COMPLETED · sponsor: **Coronado Biosciences, Inc.** · enrollment: 36 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **BIOLOGICAL:** Trichuris suis ova
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01434693
- **Lead sponsor:** Coronado Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-11
- **Primary completion:** 2012-04
- **Final completion:** 2012-09
- **Target enrollment:** 36 (ACTUAL)
- **Last updated:** 2013-05-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01434693

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01434693, "Safety and Tolerability of Single Doses Oral CNDO 201 Trichuris Suis Ova in Patients With Crohn's Disease". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01434693. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*